News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerespir Announces Chris Griffett Will Serve As Vice President, Regulatory Affairs


1/10/2014 9:03:26 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, Jan. 10, 2014 (GLOBE NEWSWIRE) -- CereSpirâ„¢ Incorporated, a company developing CHF 5074, a first-in-class microglial modulator as a potential treatment for Alzheimer's disease, today announced Chris Griffett, BSc (Hons), C.Biol., FTOPRA, will serve as the Company's Vice President, Regulatory Affairs. Mr. Griffett will report directly to Daniel G. Chain, PhD, Chairman, President and Chief Executive Officer of CereSpir.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
Cerespir
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES